
Opinion|Videos|August 6, 2024
ITB Pump for Spasticity: Surveillance Registry Findings
Experts on spasticity discuss how patients do with ITB over the long term, highlighting replacement and discontinuation data from the Product Surveillance Registry.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How well do patients with severe spasticity do with ITB over the long term?
- Discuss replacement and discontinuation data from the Product Surveillance Registry.
- What do these results add to what we already know about ITB in this patient population?
- What do these results add to what we already know about ITB in this patient population?
- Discuss replacement and discontinuation data from the Product Surveillance Registry.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis
2
Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis
3
Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers
4
CD40L Inhibitor Frexalimab Enters Phase 3 FREXITE Trial of Non-Relapsing Secondary Progressive Multiple Sclerosis
5











